Tag Archives: Expanded

Speedcast Awarded Multi-Year Contract Extension with Lindblad Expeditions Enabling Significant Bandwidth Increase Across Expanded Fleet

Expedition cruise company adds five vessels to agreement as Speedcast upgrades onboard services benefitting guests and crew across global fleet Houston, Texas — August 2, 2022 — Speedcast, a leading communications and IT services provider, announced today that the company has been awarded a multi-year contract with Lindblad Expeditions to expand their agreement to deliver… Read More »

Gilead’s Veklury wins expanded FDA nod for moderate COVID-19 patients despite mixed data

Amid daily headlines about COVID-19 vaccines and trends, Gilead’s Veklury, also known as remdesivir, remains the only antiviral drug authorized to treat the illness. With a new move from the FDA, the medicine’s emergency green light is a little broader—despite some lingering questions about its efficacy. Under the expanded emergency use authorization (EUA), all hospitalized… Read More »

FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »

FDA Approves Expanded Use of Adacel (Tdap) Vaccine for Repeat Vaccination

Print this page BRIDGEWATER, N.J., Jan. 14, 2019 /PRNewswire/ — The U.S. Food and Drug Administration has approved the expanded use of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat vaccination to help protect against tetanus, diphtheria and pertussis. It is now the first and only Tdap vaccine… Read More »